• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

M2 肿瘤相关巨噬细胞通过增强 EZH2 促进肺癌转移中的 DNA 甲基化。

M2 tumor-associated macrophage promoted DNA methylation in lung cancer metastasis via intensifying EZH2.

机构信息

College of Pharmacy, Zhejiang Chinese Medical University.

Department of Thoracic Surgery, Zhejiang Hospital, Hangzhou, China.

出版信息

Anticancer Drugs. 2024 Jan 1;35(1):22-35. doi: 10.1097/CAD.0000000000001538. Epub 2023 Aug 25.

DOI:10.1097/CAD.0000000000001538
PMID:37615534
Abstract

This study aimed to explore the interaction between the tumor-associated macrophage (TAM) and enhancer of zeste homolog 2 (EZH2) in tumor microenvironment of lung cancer are obscure. M2 type of TAM was induced by interleukin-4 (IL-4) and interleukin-13 (IL-13) in RAW264.7 cells. Subsequently, the co-culture system of the M2 RAW264.7 treating LLC-1 cells were constructed to evaluate the cell proliferation, migration and invasion abilities. On top of that, the M2 RAW264.7 was injected into the LLC-1 cells-bearing mice. Tumor growth and the number of metastatic nodes were observed. Moreover, DNA methylation, EZH2 expression, target genes of EZH2 and the M2 type TAM-related markers were detected in vivo and in vitro . Further experiments of EZH2 function in lung cancer were carried out by the addition of EZH2 inhibitor (GSK126) and si-EZH2. M2 type of TAM was induced with IL-4 and IL-13 with increased expression of CD206, CD68, CD163 and Arg1. Following co-culture with M2 type TAM, the proliferative, invasive, migrative abilities, tumor growth and metastasis, and the DNA methylation, EZH2 level were strengthened whereas the target genes of EZH2, including p21, CDKN2A, CDKN2B were reduced in LLC-1 cells and LLC-1 cell-bearing mice. Of note, GSK126 and si-EZH2 offset the M2 type TAM's effects, and inhibited the LLC-1 cell metastasis, DNA methylation and tumor growth. M2 type TAM promoted DNA methylation in LLC-1 cells and LLC-1 cell-bearing mice, which is related to the intensified EZH2.

摘要

这项研究旨在探讨肿瘤相关巨噬细胞(TAM)与增强子的锌指蛋白 2(EZH2)在肺癌肿瘤微环境中的相互作用尚不清楚。用白细胞介素 4(IL-4)和白细胞介素 13(IL-13)诱导 RAW264.7 细胞产生 M2 型 TAM。随后,构建 M2 RAW264.7 处理 LLC-1 细胞的共培养体系,评估细胞增殖、迁移和侵袭能力。此外,将 M2 RAW264.7 注射到携带 LLC-1 细胞的小鼠体内,观察肿瘤生长和转移节点数量。此外,还在体内和体外检测了 DNA 甲基化、EZH2 表达、EZH2 的靶基因和 M2 型 TAM 相关标志物。通过添加 EZH2 抑制剂(GSK126)和 si-EZH2 进一步进行肺癌中 EZH2 功能的实验。用白细胞介素 4 和白细胞介素 13 诱导 M2 型 TAM,其 CD206、CD68、CD163 和 Arg1 表达增加。与 M2 型 TAM 共培养后,LLC-1 细胞的增殖、侵袭、迁移能力、肿瘤生长和转移,以及 EZH2 水平增强,而 EZH2 的靶基因,包括 p21、CDKN2A 和 CDKN2B 降低。值得注意的是,GSK126 和 si-EZH2 抵消了 M2 型 TAM 的作用,并抑制了 LLC-1 细胞的转移、DNA 甲基化和肿瘤生长。M2 型 TAM 促进了 LLC-1 细胞和携带 LLC-1 细胞的小鼠的 DNA 甲基化,这与 EZH2 的增强有关。

相似文献

1
M2 tumor-associated macrophage promoted DNA methylation in lung cancer metastasis via intensifying EZH2.M2 肿瘤相关巨噬细胞通过增强 EZH2 促进肺癌转移中的 DNA 甲基化。
Anticancer Drugs. 2024 Jan 1;35(1):22-35. doi: 10.1097/CAD.0000000000001538. Epub 2023 Aug 25.
2
[TIPE2 inhibits the stemness of lung cancer cells by regulating the phenotypic polarization of tumor-associated macrophages].TIPE2通过调节肿瘤相关巨噬细胞的表型极化抑制肺癌细胞的干性
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2025 Aug;41(8):680-686.
3
EZH2 regulates tumor-associated macrophages by the KDM6A-mediated inflammatory response in HPV16-positive cervical cancer.EZH2通过KDM6A介导的炎症反应在HPV16阳性宫颈癌中调节肿瘤相关巨噬细胞。
Hum Cell. 2025 Jun 19;38(4):119. doi: 10.1007/s13577-025-01246-3.
4
Cancer-Derived Exosomal LINC01615 Induces M2 Polarization of Tumor-Associated Macrophages via RBMX-EZH2 Axis to Promote Colorectal Cancer Progression.癌症来源的外泌体LINC01615通过RBMX-EZH2轴诱导肿瘤相关巨噬细胞的M2极化以促进结直肠癌进展。
Int J Nanomedicine. 2025 Jun 11;20:7343-7358. doi: 10.2147/IJN.S499381. eCollection 2025.
5
Wenxia Changfu formula inhibits Lewis lung cancer metastasis by reprogramming tumor-associated macrophages through the PPAR-γ/CD36 pathway.温夏长富方通过PPAR-γ/CD36途径对肿瘤相关巨噬细胞进行重编程,从而抑制Lewis肺癌转移。
J Ethnopharmacol. 2025 Jul 24;351:120103. doi: 10.1016/j.jep.2025.120103. Epub 2025 Jun 6.
6
Nicotine promotes the progression and metastasis of non-small cell lung cancer by modulating the OTUB1-c-Myc-EZH2 axis.尼古丁通过调节OTUB1-c-Myc-EZH2轴促进非小细胞肺癌的进展和转移。
Acta Pharmacol Sin. 2025 Apr 1. doi: 10.1038/s41401-025-01527-5.
7
Artesunate modulates the tumor microenvironment via STAT1/IRF1-mediated TAM repolarization and T cell activation in non-small cell lung cancer.青蒿琥酯通过STAT1/IRF1介导的肿瘤相关巨噬细胞重极化和T细胞活化来调节非小细胞肺癌的肿瘤微环境。
Phytomedicine. 2025 Oct;146:157085. doi: 10.1016/j.phymed.2025.157085. Epub 2025 Jul 21.
8
LINC00161 upregulated by M2-like tumor-associated macrophages promotes hepatocellular carcinoma progression by methylating HACE1 promoters.由M2样肿瘤相关巨噬细胞上调的LINC00161通过甲基化HACE1启动子促进肝细胞癌进展。
Cytotechnology. 2024 Dec;76(6):777-793. doi: 10.1007/s10616-024-00653-y. Epub 2024 Aug 16.
9
Cinobufagin Inhibits Invasion and Migration of Non-Small Cell Lung Cancer via Regulating Glucose Metabolism Reprogramming in Tumor-Associated Macrophages.华蟾毒精通过调节肿瘤相关巨噬细胞中的糖代谢重编程抑制非小细胞肺癌的侵袭和迁移。
Drug Des Devel Ther. 2025 Aug 2;19:6647-6664. doi: 10.2147/DDDT.S531190. eCollection 2025.
10
Tumor-Intrinsic Enhancer of Zeste Homolog 2 Controls Immune Cell Infiltration, Tumor Growth, and Lung Metastasis in a Triple-Negative Breast Cancer Model.Zeste 同源物 2 的肿瘤内在增强子控制三阴性乳腺癌模型中的免疫细胞浸润、肿瘤生长和肺转移。
Int J Mol Sci. 2024 May 15;25(10):5392. doi: 10.3390/ijms25105392.

引用本文的文献

1
Targeting tumor-associated macrophages in gastric cancer progression and therapy: insights from molecular mechanisms to therapeutic applications.靶向肿瘤相关巨噬细胞在胃癌进展和治疗中的作用:从分子机制到治疗应用的见解
Front Pharmacol. 2025 Jun 17;16:1549694. doi: 10.3389/fphar.2025.1549694. eCollection 2025.
2
Enhancer zeste homolog 2 (EZH2) targeting by small interfering RNA (siRNA); recent advances and prospect.小干扰RNA(siRNA)靶向增强子zeste同源物2(EZH2):研究进展与展望
Naunyn Schmiedebergs Arch Pharmacol. 2025 Feb 17. doi: 10.1007/s00210-025-03883-9.